Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu‐Pei Chen, Jun Ma, Feng Jin et al.|The Lancet|2021Cited by 234
Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screeningLing Li, Jianjun Chen, Jin Liu et al.|European Journal of Medicinal Chemistry|2022Cited by 29